HOW DO I …?
How do I allocate blood products at the end of life? An ethical analysis with suggested guidelines
Article first published online: 22 APR 2012
© 2012 American Association of Blood Banks
Volume 53, Issue 4, pages 696–700, April 2013
How to Cite
Smith, L. B., Cooling, L. and Davenport, R. (2013), How do I allocate blood products at the end of life? An ethical analysis with suggested guidelines. Transfusion, 53: 696–700. doi: 10.1111/j.1537-2995.2012.03658.x
- Issue published online: 8 APR 2013
- Article first published online: 22 APR 2012
- Received for publication October 5, 2011; revision received February 27, 2012, and accepted February 29, 2012.
Blood products are scarce resources requiring prudent and reasoned allocation. The utilization of red blood cells and platelets in terminally ill patients can be complicated and requires guidelines tempered by individualized considerations. Representative cases are discussed in which blood products are requested or utilized by patients at the end of life. Relevant literature is reviewed and ethical issues pertaining to each case are discussed. A practical approach to blood product utilization at the end of life is suggested.